Castle Biosciences
$27.199876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$27.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$2.82 (-9.38%) Today
$0.00 (0.00%) As of 4:00 PM EST after-hours
Why Robinhood?
You can buy or sell CSTL and other stocks, options, ETFs, and crypto commission-free!
About CSTL
Castle Biosciences, Inc. Common Stock, also called Castle Biosciences, is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. Read More The company offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, which is a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Employees
—
Headquarters
Friendswood, Texas
Founded
2007
Market Cap
569.25M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
142.43K
High Today
$30.90
Low Today
$27.01
Open Price
$30.16
Volume
118.93K
52 Week High
$39.77
52 Week Low
$15.26
Collections
CSTL Earnings
-$1.05
-$0.69
-$0.34
$0.02
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 5, After Hours
People Also Bought
Uber
132,488
$35.85
-6.42%Dynatrace
1,887
$32.60
-1.02%Lyft
56,455
$41.95
-1.34%Slack
57,915
$26.40
-5.44%Canopy Growth
178,364
$19.59
-3.50%Livongo
4,524
$25.27
-6.86%Aurora Cannabis
672,305
$1.50
-3.23%Viking Therapeutics
39,315
$6.56
-3.95%Personalis
439
$8.52
-7.89%Hexo
166,386
$1.26
-3.82%Health Catalyst
1,197
$29.57
-1.79%Adaptive Biotechnologies
2,818